UK markets closed

Keros Therapeutics, Inc. (KROS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
60.57+3.47 (+6.08%)
At close: 04:00PM EDT
61.74 +1.17 (+1.93%)
After hours: 04:26PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts10101110
Avg. Estimate-1.35-1.34-5.27-5.47
Low estimate-1.62-1.7-6.3-6.98
High estimate-1.2-1.1-4.41-3.72
Year ago EPS-1.26-1.27-5.2-5.27
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts8899
Avg. EstimateN/AN/A6.3M20k
Low estimateN/AN/AN/AN/A
High estimateN/AN/A30M200k
Year ago sales220kN/A151k6.3M
Sales growth (year/est)N/AN/A4,072.20%-99.70%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.12-1.34-1.35-1.37
Actual EPS-1.26-1.27-1.33-1.34
Difference-0.140.070.020.03
Surprise %-12.50%5.20%1.50%2.20%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.35-1.34-5.27-5.47
7 days ago-1.35-1.34-5.27-5.47
30 days ago-1.35-1.34-5.27-5.47
60 days ago-1.34-1.33-5.21-5.5
90 days ago-1.36-1.39-5.35-5.68
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesKROSIndustrySector(s)S&P 500
Current qtr.-7.10%N/AN/AN/A
Next qtr.-5.50%N/AN/AN/A
Current year-1.30%N/AN/AN/A
Next year-3.80%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A